BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Psychiatry. May 19, 2026; 16(5): 113822
Published online May 19, 2026. doi: 10.5498/wjp.v16.i5.113822
Table 5 Correlation of the change amplitude of brain-derived neurotrophic factor with the reduction of negative symptoms and the shortening of Trail Making Test completion time
Category
r
P value
BDNF change amplitude (points)0.0330.709
Reduction of negative symptoms (points)
BDNF change amplitude (points)0.0420.641
Shortening of TMT completion time (second)


Write to the Help Desk